遺伝子検査の世界市場2018-2022

◆英語タイトル:Global Genetic Testing Market 2018-2022
◆商品コード:IRTNTR21575
◆発行会社(リサーチ会社):Technavio
◆発行日:2018年2月21日
◆ページ数:140
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、遺伝子検査の世界市場について調査・分析し、市場概要、市場環境、遺伝子検査市場規模、用途別(予測検査・診断検査、出生前・新生児・着床前検査、薬理ゲノミクス検査、法医学・親子関係・祖先検査)分析、製品別(分析装置、消耗品)分析、エンドユーザー別(臨床診断研究所、病院、バイオ医薬品企業・研究センター)分析、市場動向、競争環境、主要地域別市場規模(アメリカ、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・遺伝子検査の世界市場概要
・遺伝子検査の世界市場環境
・遺伝子検査の世界市場動向
・遺伝子検査の世界市場規模
・遺伝子検査の世界市場:業界構造分析
・遺伝子検査の世界市場:用途別(予測検査・診断検査、出生前・新生児・着床前検査、薬理ゲノミクス検査、法医学・親子関係・祖先検査)
・遺伝子検査の世界市場:製品別(分析装置、消耗品)
・遺伝子検査の世界市場:エンドユーザー別(臨床診断研究所、病院、バイオ医薬品企業・研究センター)
・遺伝子検査の世界市場:地域別市場規模・分析
・遺伝子検査のアメリカ市場規模・予測
・遺伝子検査のヨーロッパ市場規模・予測
・遺伝子検査のアジア市場規模・予測
・遺伝子検査の主要国分析
・遺伝子検査の世界市場:意思決定フレームワーク
・遺伝子検査の世界市場:成長要因、課題
・遺伝子検査の世界市場:競争環境
・遺伝子検査の世界市場:関連企業情報(ベンダー分析)
【レポートの概要】

About Genetic Testing
Genetic testing refers to an array of techniques used to analyze nucleic acids such as deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins. The results of the analysis determine the genetic defects caused by hereditary, chronic, and infectious diseases. Genetic testing is a rapidly growing segment of molecular diagnostics. Genetic tests can be used in non-clinical applications such as forensics and relationship testing. Genetic tests identify the genetic cause of diseases. They can predict the possibility of diseases in the future and help initiate precautionary measures and treatments in advance.
Technavio’s analysts forecast the global genetic testing market to grow at a CAGR of 10.32% during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the Global Genetic Testing Market 2018-2022.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Genetic Testing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Abbott, bioMérieux, Bio-Rad Laboratories, F. Hoffmann-La Roche, Myriad Genetics, QIAGEN, Quest Diagnostics
Market driver
• increasing prevalence of genetic disorders
• For a full, detailed list, view our report

Market challenge
• High cost associated with genetic testing

• For a full, detailed list, view our report

Market trend
• Growing demand for companion diagnostics
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

Table of ContentsPART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: SEGMENTATION BY APPLICATION
• Overview
• Predictive and diagnostic testing
• Prenatal, newborn, and pre-implantation testing
• Pharmacogenomic testing
• Forensic, relationship, and ancestry testing
PART 08: SEGMENTATION BY PRODUCT
• Overview
• Comparison by product
• Analyzers
• Consumables
• Market opportunity by product
PART 09: CUSTOMER LANDSCAPE
PART 10: SEGMENTATION BY END-USER
• Overview
• Clinical diagnostics laboratories
• Hospitals
• Biopharmaceuticals companies and research centers
PART 11: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Genetic testing market in Americas
• Genetic testing market in EMEA
• Genetic testing market in APAC
• Market opportunity
PART 12: DECISION FRAMEWORK
PART 13: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 14: MARKET TRENDS
• Growing demand for companion diagnostics
• Availability of NGS for present and future genetic diagnosis
• Growing adoption of DTC genetic testing
PART 15: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive landscape
PART 16: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• bioMérieux
• Bio-Rad Laboratories
• F. Hoffmann-La Roche
• Myriad Genetics
• QIAGEN
• Quest Diagnostics
PART 17: APPENDIX
• List of abbreviations
Exhibit 01: Parent market: Global IVD market
Exhibit 02: Global IVD market: Segments
Exhibit 03: Market characteristics
Exhibit 04: Global genetic testing market: Segments
Exhibit 05: Market definition: Inclusions and exclusions checklist
Exhibit 06: Global genetic testing market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global genetic testing market 2017-2022 ($ millions)
Exhibit 09: Global genetic testing market: Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition: Five forces 2017
Exhibit 18: Global genetic testing market: Segmentation by application 2017 (% share)
Exhibit 19: Global genetic testing market: Segmentation by product 2017-2022 (% share)
Exhibit 20: Global genetic testing market: Comparison by product
Exhibit 21: Global genetic testing analyzers market 2017-2022 ($ millions)
Exhibit 22: Global genetic testing analyzers market: Year-over-year growth 2018-2022 (%)
Exhibit 23: Global genetic testing consumables market 2017-2022 ($ millions)
Exhibit 24: Global genetic testing consumables market: Year-over-year growth 2018-2022 (%)
Exhibit 25: Market opportunity by product
Exhibit 26: Customer landscape
Exhibit 27: Global genetic testing market: Segmentation by end-user 2017 (% share)
Exhibit 28: Global genetic testing market: Segmentation by geography 2017-2022 (% share)
Exhibit 29: Regional comparison
Exhibit 31: Genetic testing market in Americas 2017-2022 ($ millions)
Exhibit 32: Genetic testing market in Americas: Year-over-year growth 2018-2022 (%)
Exhibit 33: Top-three countries in Americas
Exhibit 34: Genetic testing market in EMEA 2017-2022 ($ millions)
Exhibit 35: Genetic testing market in EMEA: Year-over-year growth 2018-2022 (%)
Exhibit 36: Top-three countries in EMEA
Exhibit 37: Genetic testing market in APAC 2017-2022 ($ millions)
Exhibit 38: Genetic testing market in APAC: Year-over-year growth 2018-2022 (%)
Exhibit 39: Top-three countries in APAC
Exhibit 40: Market opportunity
Exhibit 41: Product approvals in few countries and their market impact analysis
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Abbott: Overview
Exhibit 48: Abbott: Business segments
Exhibit 49: Abbott: Organizational developments
Exhibit 50: Abbott: Geographic focus
Exhibit 51: Abbott: Segment focus
Exhibit 52: Abbott: Key offerings
Exhibit 53: Abbott: Key customers
Exhibit 54: bioMérieux: Overview
Exhibit 55: bioMérieux: Business segments
Exhibit 56: bioMérieux: Organizational developments
Exhibit 57: bioMérieux: Geographic focus
Exhibit 58: bioMérieux: Segment focus
Exhibit 59: bioMérieux: Key offerings
Exhibit 60: bioMérieux: Key customers
Exhibit 61: Bio-Rad Laboratories: Overview
Exhibit 62: Bio-Rad Laboratories: Business segments
Exhibit 63: Bio-Rad Laboratories: Organizational developments
Exhibit 64: Bio-Rad Laboratories: Geographic focus
Exhibit 65: Bio-Rad Laboratories: Segment focus
Exhibit 66: Bio-Rad Laboratories: Key offerings
Exhibit 67: Bio-Rad Laboratories: Key customers
Exhibit 68: F. Hoffmann-La Roche: Overview
Exhibit 69: F. Hoffmann-La Roche: Business segments
Exhibit 70: F. Hoffmann-La Roche: Organizational developments
Exhibit 71: F. Hoffmann-La Roche: Geographic focus
Exhibit 72: F. Hoffmann-La Roche: Segment focus
Exhibit 73: F. Hoffmann-La Roche: Key offerings
Exhibit 74: F. Hoffmann-La Roche: Key customers
Exhibit 75: Myriad Genetics: Overview
Exhibit 76: Myriad Genetics: Business segments
Exhibit 77: Myriad Genetics: Organizational developments
Exhibit 78: Myriad Genetics: Geographic focus
Exhibit 79: Myriad Genetics: Segment focus
Exhibit 80: Myriad Genetics: Key offerings
Exhibit 81: Myriad Genetics: Key customers
Exhibit 82: QIAGEN: Overview
Exhibit 83: QIAGEN: Product categories
Exhibit 84: QIAGEN: Organizational developments
Exhibit 85: QIAGEN: Geographic focus
Exhibit 86: QIAGEN: Product categories focus
Exhibit 87: QIAGEN: Key offerings
Exhibit 88: QIAGEN: Key customers
Exhibit 89: Quest Diagnostics: Overview
Exhibit 90: Quest Diagnostics: Business segments
Exhibit 91: Quest Diagnostics: Organizational developments
Exhibit 92: Quest Diagnostics: Geographic focus
Exhibit 93: Quest Diagnostics Segment focus
Exhibit 94: Quest Diagnostics Key offerings
Exhibit 95: Quest Diagnostics: Key customers



【掲載企業】

Abbott
bioMérieux
Bio-Rad Laboratories
F. Hoffmann-La Roche
Myriad Genetics
QIAGEN
Quest Diagnostics

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[遺伝子検査の世界市場2018-2022]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆